Bharat Biotech completes enrollment of 25,800 volunteers for Covaxin Phase-3 trials
Hyderabad: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin. This information ...
Read moreHyderabad: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin. This information ...
Read moreNew Delhi: The Union Health Ministry has informed states and Union Territories (UTs) that they are likely to receive the ...
Read moreNew Delhi: Union Health Minister Harsh Vardhan is slated to hold a video conferencing Thursday with health ministers of all ...
Read moreHyderabad: A day after ‘Bharat Biotech’ slammed Serum Institute of Indias (SII) CEO Adar Poonawalla for his ‘water’ comment about ...
Read moreNew Delhi/Hyderabad: Hyderabad-based Bharat Biotech rejected Monday criticism over the grant of emergency use authorisation by India’s drug regulator to ...
Read moreHyderabad: Bharat Biotech has been accorded emergency use authorisation from the drug regulator for its COVID-19 vaccine Covaxin. The company ...
Read moreNew Delhi: Some healthcare experts Monday questioned the government’s assertion that Bharat Biotech’s COVID-19 vaccine Covaxin can target mutated coronavirus ...
Read moreNew Delhi: Congress leader Shashi Tharoor has criticised the government for giving the nod to Bharat Biotech's Covid vaccine without ...
Read moreNew Delhi: The Central Licensing Authority Saturday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, ...
Read moreNew Delhi: Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India ...
Read more